Evidence map›Paper›PMID 42050654›Full record

ArticleBehavioral and brain functions : BBF2026

Low-level laser therapy enhances neuroprotection and functional recovery after neonatal hypoxic-ischemic injury via potential activation of Nrf2/HO-1 and Akt pathways.

Ping Liu, Sunxin Zhang, Huan Wang, Zhili Li

Abstract read
In one paragraph

Article in Behavioral and brain functions : BBF, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ping Liu *Department of Neurosurgery, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, University of Electronic Science and Technology of China, Chengdu, China.
Sunxin Zhang *Department of Neurosurgery, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, University of Electronic Science and Technology of China, Chengdu, China.
Huan WangDepartment of Haematology, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, University of Electronic Science and Technology of China, Chengdu, China. huanwang2@proton.me.
Zhili LiDepartment of Neurosurgery, Sichuan Provincial People's Hospital, Sichuan Academy of Medical Sciences, University of Electronic Science and Technology of China, Chengdu, China. ZhiliLi@proton.me.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeonatal hypoxic–ischemic encephalopathy (HIE) is a leading cause of neurodevelopmental disability. Low-level laser therapy (LLLT), or photobiomodulation, has shown neuroprotective potential, but its long-term effects and region-specific responses remain poorly defined.

methodsNeonatal rats subjected to hypoxic–ischemic brain damage (HIBD) received transcranial 810-nm LLLT (24 mW/cm², 10 min/session, twice daily for three days). Histological, immunofluorescence, and Western blot analyses assessed neuronal integrity, glial activation, and signaling pathway changes. Sensorimotor function was evaluated by grip traction and open-field tests, and spatial learning and memory were assessed using the Morris water maze (MWM) at long-term follow-up.

resultsLLLT reduced neuronal loss and glial reactivity and was associated with increased Nrf2/HO-1 and Akt signaling at early time points. Behaviorally, LLLT improved motor and cognitive performance, with benefits persisting up to 20 weeks post-injury.

conclusionEarly LLLT is associated with sustained functional recovery after neonatal hypoxic–ischemic injury. These effects may involve early modulation of antioxidant and pro-survival signaling pathways, although the mechanisms underlying long-term outcomes require further investigation.

Indexed as

Hypoxia-Ischemia, BrainLow-Level Light TherapyNeuroprotectionNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktRecovery of FunctionAnimalsAnimals, NewbornHeme Oxygenase-1MaleMaze LearningNeuronsRatsRats, Sprague-DawleySignal TransductionHeme Oxygenase-1Nfe2l2 protein, ratNF-E2-Related Factor 2Proto-Oncogene Proteins c-aktAktGFAPHO-1Hypoxia–ischemia brain injuryLow-level laser therapyneuroprotectionNrf2

Identifiers

PMID42050654
PMCPMC13274093

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.